PDS Biotechnology announced the appointment of Lars Boesgaard as Chief Financial Officer, CFO, effective as of December 4, 2023. Boesgaard succeeds Matthew Hill, who resigned as PDS Biotech’s CFO on November 21, 2023, effective December 1, 2023, to pursue other professional endeavors. Prior to joining PDS Biotech, Boesgaard served as CFO of AM-Pharma B.V. from September 2021 to August 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PDSB:
- PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
- PDS Biotechnology reports Q3 EPS (35c), consensus (45c)
- PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
- PDS Biotechnology announces updated survival data from Phase 2 trial of PDS0101
- PDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of PDS0101-Based Triple Combination Therapy in Advanced HPV16-Positive Cancer Patients which Show 75% Survival of ICI Naïve Patients at 36 Months
